SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-19-019176
Filing Date
2019-12-13
Accepted
2019-12-13 16:00:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 78418
  Complete submission text file 0001493152-19-019176.txt   80137
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88750 | Film No.: 191284577
SIC: 2834 Pharmaceutical Preparations

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A